Gerd R Pape
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial
Kronenberger B, Hopf U, Pape G, Wursthorn K, Nasser S, Goeser T, Spengler U, Buggisch P, Gerlach T, Hinrichsen H, Herrmann E, Berg T, Zeuzem S. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. European journal of gastroenterology & hepatology 2007; 19:639-46.
01.08.2007Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial
01.08.2007European journal of gastroenterology & hepatology 2007; 19:639-46
Kronenberger Bernd, Hopf Uwe, Pape Gerd R, Wursthorn Karsten, Nasser Samer, Goeser Tobias, Spengler Ulrich, Buggisch Peter, Gerlach Tilman, Hinrichsen Holger, Herrmann Eva, Berg Thomas, Zeuzem Stefan
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
Lucas M, Santantonio T, Fidler S, Thimme R, Haberstroh A, Baumert T, Klenerman P, Diepolder H, Nitschko H, Obermeier M, Phillips R, Scriba T, Semmo N, Day C, Weber J, Schraut W, Pape G, Zachoval R, Ulsenheimer A, Pfafferot K, Heeg M, Gaudieri S, Grüner N, Rauch A, Gerlach T, Jung M. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PloS one 2007; 2:e649.
01.01.2007Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
01.01.2007PloS one 2007; 2:e649
Lucas Michaela, Santantonio Teresa, Fidler Sarah, Thimme Robert, Haberstroh Anita, Baumert Thomas F, Klenerman Paul, Diepolder Helmut M, Nitschko Hans, Obermeier Martin, Phillips Rodney, Scriba Thomas J, Semmo Nasser, Day Cheryl, Weber Jonathan N, Schraut Winfried, Pape Gerd R, Zachoval Reinhart, Ulsenheimer Axel, Pfafferot Katja, Heeg Malte H J, Gaudieri Silvana, Grüner Norbert, Rauch Andri, Gerlach Tilman, Jung Maria-Christina
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
Berg T, Alshuth U, Martus P, Spengler U, Klinker H, Kallinowski B, Schmidt W, Pape G, Rasenack J, Goeser T, Buggisch P, Gerlach T, Heintges T, Sarrazin C, Nasser S, von Wagner M, Zeuzem S. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 2006; 130:1086-97.
01.04.2006Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
01.04.2006Gastroenterology 2006; 130:1086-97
Berg Thomas, Alshuth Ulrich, Martus Peter, Spengler Ulrich, Klinker Hartwig, Kallinowski Birgit, Schmidt Wolfgang E, Pape Gerd R, Rasenack Jens, Goeser Tobias, Buggisch Peter, Gerlach Tilman, Heintges Tobias, Sarrazin Christoph, Nasser Samer, von Wagner Michael, Zeuzem Stefan
Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
Ulsenheimer A, Pape G, Zachoval R, Schirren C, Heeg M, Schraut W, Santantonio T, Backmund M, Wächtler M, Gruener N, Jung M, Gerlach T, Diepolder H. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology (Baltimore, Md.) 2005; 41:643-51.
01.03.2005Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
01.03.2005Hepatology (Baltimore, Md.) 2005; 41:643-51
Ulsenheimer Axel, Pape Gerd R, Zachoval Reinhart, Schirren Carl A, Heeg Malte H J, Schraut Winfried, Santantonio Teresa, Backmund Markus, Wächtler Martin, Gruener Norbert, Jung Maria-Christina, Gerlach Tilman, Diepolder Helmut M
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
Steinmann D, Blum H, Liang T, Inchauspé G, Patel A, Maertens G, Jacobs D, Depla E, Pape G, Gerlach T, Adah M, Schürmann P, Gissler B, Barth H, Baumert T. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. Journal of virology 2004; 78:9030-40.
01.09.2004Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
01.09.2004Journal of virology 2004; 78:9030-40
Steinmann Daniel, Blum Hubert E, Liang T Jake, Inchauspé Geneviève, Patel Arvind H, Maertens Geert, Jacobs Dirk, Depla Erik, Pape Gerd R, Gerlach Tilman, Adah Mohammed I, Schürmann Peter, Gissler Bettina, Barth Heidi, Baumert Thomas F
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
Gerlach T, Backmund M, Waechtler M, Schirren C, Schraut W, Ulsenheimer A, Jung M, Gruener N, Zachoval R, Diepolder H, Pape G. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125:80-8.
01.07.2003Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance
01.07.2003Gastroenterology 2003; 125:80-8
Gerlach Tilman, Backmund M, Waechtler M, Schirren C Albrecht, Schraut Winfried W, Ulsenheimer Axel, Jung Maria-Christina, Gruener Norbert H, Zachoval Reinhart, Diepolder Helmut M, Pape Gerd R
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial
Berg T, Hopf U, Pape G, Wursthorn K, Nasser S, Goeser T, Spengler U, Herrmann E, Buggisch P, Gerlach T, Hinrichsen H, Kronenberger B, Zeuzem S. Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. Hepatology (Baltimore, Md.) 2003; 37:1359-67.
01.06.2003Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial
01.06.2003Hepatology (Baltimore, Md.) 2003; 37:1359-67
Berg Thomas, Hopf Uwe, Pape Gerd R, Wursthorn Karsten, Nasser Samer, Goeser Tobias, Spengler Ulrich, Herrmann Eva, Buggisch Peter, Gerlach Tilman, Hinrichsen Holger, Kronenberger Bernd, Zeuzem Stefan
Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
Ulsenheimer A, Gerlach T, Gruener N, Jung M, Schirren C, Schraut W, Zachoval R, Pape G, Diepolder H. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology (Baltimore, Md.) 2003; 37:1189-98.
01.05.2003Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C
01.05.2003Hepatology (Baltimore, Md.) 2003; 37:1189-98
Ulsenheimer Axel, Gerlach Tilman, Gruener Norbert H, Jung Maria-Christina, Schirren Carl-Albrecht, Schraut Winfried, Zachoval Reinhart, Pape Gerd R, Diepolder Helmut M
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
Gruener N, Backmund M, Wächtler M, Hoffmann R, Schirren C, Diepolder H, Gerlach T, Ulsenheimer A, Jung M, Pape G. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. Journal of hepatology 2002; 37:866-9.
01.12.2002Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
01.12.2002Journal of hepatology 2002; 37:866-9
Gruener Norbert H, Backmund Markus, Wächtler Martin, Hoffmann Robert, Schirren Carl A, Diepolder Helmut M, Gerlach Tilman, Ulsenheimer Axel, Jung Maria-Christina, Pape Gerd R
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
Jung M, Zeuzem S, Trojan J, Whitehead E, Birtles E, Bailey J, Page M, Schirren C, Diepolder H, Gerlach T, Schraut W, Zachoval R, Grüner N, Pape G. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 2002; 20:3598-612.
04.10.2002Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
04.10.2002Vaccine 2002; 20:3598-612
Jung Maria-Christina, Zeuzem Stefan, Trojan Jörg, Whitehead Eve, Birtles Emma, Bailey John, Page Mark, Schirren Carl-Albrecht, Diepolder Helmut, Gerlach Tilman, Schraut Winfried, Zachoval Reinhart, Grüner Norbert, Pape Gerd R